Short interest in Supernus Pharmaceuticals Inc (NASDAQ:SUPN) decreased during the last reporting period, falling from 6.52M to 6.45M. This put 17.91% of the company's publicly available shares short.

Short interest for Supernus Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Supernus Pharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 253.02K shares traded per day, it would take 25.51 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.